Genital herpes is a sexually transmitted infection caused by herpes simplex viruses. Type 2 (HSV‑2) is usually responsible, but type 1 (HSV‑1), which normally causes cold sores, can also affect the genital region. Transmission occurs through direct skin or mucous membrane contact during sexual intercourse, but also during oral sex. The infection is particularly contagious when visible blisters are present, but the virus can also be transmitted without symptoms. After the initial infection, the virus remains in the nerve ganglia for life and can be reactivated again and again. The initial infection is often more severe than later outbreaks. After an incubation period of two to twelve days, the first symptoms are tingling, burning or pain in the genital region. Then grouped, painful blisters form on a reddened background on the penis, vulva, vagina, cervix, anus or surrounding areas. The blisters burst and leave behind painful ulcers. In addition, fever, headaches, muscle pain and swollen lymph nodes in the groin area may occur. Urination can be very painful. Healing takes two to three weeks. Recurrences occur in around 50 percent of those infected, usually triggered by stress, illness, menstruation or immunodeficiency. These recurrences are usually milder and heal more quickly. The diagnosis is made clinically and can be confirmed by a swab from the vesicles with virus detection using PCR. A blood test for antibodies is also possible. A cure is not possible as the virus remains in the body for life. Treatment is aimed at alleviating symptoms and shortening outbreaks. Antiviral drugs such as acyclovir, valaciclovir or famciclovir should be taken at the first signs and shorten the duration and severity of symptoms. In the case of frequent recurrences, long-term suppressive therapy may be advisable. Sexual intercourse should be avoided during an outbreak. Condoms reduce the risk of transmission, but do not offer complete protection.
December 24, 2024, to December 27, 2024: No dermatology consultations or aesthetic treatments.
December 23, 2024, December 30, 2024, and December 31, 2024: Dermatology consultations available.
December 24, 2024, December 27, 2024, and December 28, 2024: Cosmetic treatments available.
December 20, 2024, and December 31, 2024: Cosmetic treatments available.
January 1, 2025, to January 2, 2025: No cosmetic treatments or dermatology consultations.